Evidence-Based Medicine Chasm: Can CMS, Industry Find Common Ground?

CMS' growing emphasis on evidence-based medicine to inform reimbursement decisions increasingly will lead manufacturers to conduct "high-quality" clinical trials, according to Chief Medical Officer Sean Tunis

More from Archive

More from Medtech Insight